Gyncentrum Sp. z o.o.
- Address
- Ul. Jozefa Mehoffera 10, 31-322 Krakow, Poland
Bacterial Infections and Mycoses
Gyncentrum is conducting studies that assess new treatments for bacterial vaginosis, aiming to confirm that novel vaginal tablets are at least as effective as existing creams.
- Evaluation of non‑inferior efficacy compared with standard therapy
- Assessment of safety and tolerability in women of reproductive age
These trials support improved management options for women experiencing vaginal infections.
Cardiovascular Diseases
Research at the Cracow site focuses on conditions such as acute myocardial infarction. It also evaluates therapies for heart failure, testing options that may lower the risk of cardiovascular death and major adverse events.
- Prevention of recurrent heart attacks
- Reduction of hospitalization for heart failure
- Improvement of lipid profiles to curb atherosclerotic disease
The work aims to provide safer, more effective options for patients with high cardiovascular risk.
Musculoskeletal Diseases
The centre evaluates interventions for knee osteoarthritis, targeting chronic pain relief and enhanced joint function.
- Assessment of analgesic efficacy
- Impact on daily activity and mobility
Successful outcomes could expand therapeutic choices for individuals living with degenerative joint disease.
Respiratory Tract Diseases
Studies include patients with asthma, comparing inhaler formulations to determine safety and optimal symptom control.
- Evaluation of new propellant technology
- Monitoring of lung function and exacerbation rates
Findings will guide future inhaled medication development for chronic respiratory conditions.
Skin and Connective Tissue Diseases
Ongoing trials address chronic spontaneous urticaria, investigating whether emerging agents can more effectively reduce hives and itching.
- Measurement of symptom frequency and severity
- Quality‑of‑life assessments
Improved treatments could significantly enhance daily comfort for affected patients.
Virus Diseases
The site participates in antiviral research targeting COVID‑19, evaluating oral medications that may prevent severe disease and hospitalization.
- Reduction of viral load and symptom duration
- Safety profile in high‑risk adult populations
Positive results would add valuable tools to the public health response against pandemic viruses.
Reproductive and Urinary Physiological Phenomena
Investigations include a contraceptive device designed to demonstrate reliable contraceptive efficacy over multiple cycles.
- Confirmation of pregnancy prevention rates
- Evaluation of tolerability and cycle regularity
Successful data will support broader availability of female‑controlled birth control options.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1AstraZeneca AB1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Gyncentrum Sp. z o.o.
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A multicentre, single arm trial on contraceptive efficacy, safety and tolerability of LVDS (Levonorgestrel Vaginal Delivery System) during 13 cycles. | Chemo Research S.L. | Phase III | Not Recruiting | Jul 2023 | Aug 2025 |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Balcinrenone | 1 | Unknown | 2024-07-12 | 2024-07-12 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.